Michael Einstein

Summary

Affiliation: University of Wisconsin
Country: USA

Publications

  1. ncbi Liver transplantation: an update
    Adnan Said
    Section of Gastroenterology and Hepatology, University of Wisconsin Madison, School of Medicine and Public Health, 53792, USA
    Curr Opin Gastroenterol 22:272-8. 2006
  2. ncbi Liver transplantation: an update 2007
    Adnan Said
    Section of Gastroenterology and Hepatology, University of Wisconsin Madison, School of Medicine and Public Health, Madison, WI 53792, USA
    Curr Opin Gastroenterol 23:292-8. 2007
  3. ncbi Liver transplantation: an update 2008
    Adnan Said
    Section of Gastroenterology and Hepatology, University of Wisconsin Madison, School of Medicine and Public Health, Madison, Wisconsin, USA
    Curr Opin Gastroenterol 24:339-45. 2008
  4. ncbi Management of hepatocellular carcinoma
    A Said
    Department of Gastroenterology and Hepatology, University of Wisconsin, School of Medicine and Public Health, Madison, WI 53792, USA
    Minerva Med 100:51-68. 2009
  5. ncbi Vasoconstrictor use in liver transplantation: is there evidence for rational use?
    C L Skagen
    Department of Medicine, University of Wisconsin, Madison, WI, USA
    Minerva Gastroenterol Dietol 56:279-96. 2010
  6. ncbi Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome
    Catherine Skagen
    Section of Gastroenterology and Hepatology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA
    J Clin Gastroenterol 43:680-5. 2009

Collaborators

Detail Information

Publications6

  1. ncbi Liver transplantation: an update
    Adnan Said
    Section of Gastroenterology and Hepatology, University of Wisconsin Madison, School of Medicine and Public Health, 53792, USA
    Curr Opin Gastroenterol 22:272-8. 2006
    ..Recent attention in liver transplantation has focused on equity in organ allocation and management of post-transplant complications...
  2. ncbi Liver transplantation: an update 2007
    Adnan Said
    Section of Gastroenterology and Hepatology, University of Wisconsin Madison, School of Medicine and Public Health, Madison, WI 53792, USA
    Curr Opin Gastroenterol 23:292-8. 2007
    ..Recent attention in liver transplantation has focused on equity in organ allocation and management of posttransplant complications...
  3. ncbi Liver transplantation: an update 2008
    Adnan Said
    Section of Gastroenterology and Hepatology, University of Wisconsin Madison, School of Medicine and Public Health, Madison, Wisconsin, USA
    Curr Opin Gastroenterol 24:339-45. 2008
    ..Expansion of the donor pool for liver transplantation is a priority. Management of hepatitis C and hepatocellular carcinoma has focused on decreasing recurrence rates after transplantation...
  4. ncbi Management of hepatocellular carcinoma
    A Said
    Department of Gastroenterology and Hepatology, University of Wisconsin, School of Medicine and Public Health, Madison, WI 53792, USA
    Minerva Med 100:51-68. 2009
    ..Further research in good biologic predictors of HCC recurrence is needed and will be invaluable in planning therapies...
  5. ncbi Vasoconstrictor use in liver transplantation: is there evidence for rational use?
    C L Skagen
    Department of Medicine, University of Wisconsin, Madison, WI, USA
    Minerva Gastroenterol Dietol 56:279-96. 2010
    ..Optimal outcomes including postoperative patient and graft survival, hospital stay and renal function should also be incorporated in future trials of vasoconstrictor therapy during liver transplantation...
  6. ncbi Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome
    Catherine Skagen
    Section of Gastroenterology and Hepatology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA
    J Clin Gastroenterol 43:680-5. 2009
    ..The combination of octreotide, midodrine, and albumin has shown possible benefit in small preliminary studies in improving renal function and short-term survival...